Editorial Board
1. Editors-in-Chief & Section Editors
Axel Merseburger
Editor-in-Chief
Professor of Urology and Chairman of the Department of Urology at University Hospital Schleswig Holstein, Campus Lübeck, Germany
Maurice Pérol (Lung Cancer)
Head, Thoracic Oncology, Medical Oncology Department, Léon Bérard Cancer Center, Lyon, France
Paolo A Ascierto (Dermatological Cancers)
Director, Unit of Melanoma, Cancer Immunotherapy and Innovative therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy
John L Marshall (Gastrointestinal Cancers)
Chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital; Professor of Medicine and Oncology, Lombardi Comprehensive Cancer Center; Director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer Georgetown University, WA, USA
David G Mutch (Gynaecological Oncology)
Ira C. and Judith Gall Professor of Obstetrics and Gynecology; Vice Chair, Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA
Eleni Andreopoulou (Breast Cancer)
Associate Professor of Clinical Medicine, Department of Medicine, Weill Cornell Medicine; Director, Breast Cancer Clinical Research, New York Presbyterian Hospital, New York, NY, USA
Matti S Aapro (Supportive Oncology)
Dean, Multidisciplinary Oncology Institute, Genolier, Switzerland
2. Advisory Board
Domenica Lorusso
Director of Gynaecological Oncology Unit at Humanitas Hospital San Pio X, Milan, and Full Professor of Obstetrics and Gynaecology, Humanitas University, Rozzano, Milan
Michael K Gibson
Director of Translational Research for Esophago-Gastric Cancer (EGC) and Associate Professor of Medicine, Vanderbilt-Ingram Cancer Center (VICC), Nashville, Tennessee
Ken Kato
Medical Oncologist and Chief of the Department of Head and Neck, Esophageal Medical Oncology, and Gastrointestinal Medical Oncology at the National Cancer Center Hospital, Tokyo, Japan
Dean A. Fennell
Professor of Thoracic Oncology and Director, Leicester Mesothelioma Research Programme, Leicester Cancer Research Centre, University of Leicester, UK
Charlie Gourley
Clinical Director, Cancer Research UK Edinburgh Centre and Director, Nicola Murray Centre for Ovarian Cancer Research, Edinburgh, UK
Véronique Diéras
Senior Medical Oncologist, Department of Medical Oncology, Centre Eugène Marquis, Rennes, France
Winette van der Graaf
Professor of Transformative Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands
Pamela Kearns
Professor of Clinical Paediatric Oncology; Honorary Paediatric Oncologist, Department of Paediatric Oncology, Birmingham Women's and Children's NHS Foundation Trust, University of Birmingham; Director, the Institute of Cancer and Genomic Sciences; Director, UK Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
Jorge Cortes
Director, Georgia Cancer Center, Augusta University, Augusta, GA, USA
Emma Searle
Consultant Haematologist, The Christie Hospital NHS Foundation Trust; Honorary Senior Lecturer, University of Manchester, Manchester, UK
Mohammad Ammad-Ud-Din
Internist, Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA
Ticiana Leal
Associate Professor, Department of Hematology & Oncology; Director, Thoracic Medical Oncology Program, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Inga Peters
Urologist; Senior Lecturer; Department of Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany
Bruce D Minsky
Professor; Director of Clinical Research, Department of Gastrointestinal (GI) Radiation Oncology Section, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Marc Peeters
CEO, Antwerp University Hospital; Professor of Oncology, Antwerp University, Antwerp, Belgium
Suchita Pakkala
Site Medical Director, Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
Martin Hutchings
Haemato-oncologist, Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Daniel Kelly OBE
Professor, Royal College of Nursing Chair of Nursing Research, School of Healthcare Sciences, Cardiff University, Cardiff, UK
Lena Sharp
Head, Regional Cancer Center, Division of Innovative Care Research, LIME, Karolinska Institutet, Stockholm, Sweden
Mario Mandalà
Associate Professor of Medical Oncology, Department of Oncology, University of Perugia, Perugia, Italy
Shaji Kumar
Professor of Medicine, Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
Bernardo Rapoport
Specialist Physician; Medical Oncologist, The Medical Oncology Centre of Rosebank, Johannesburg, South Africa
Elias Jabbour
Professor of Medicine, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Bertrand Tombal
Professor of Urology; Chairman, Service d’Urologie, Cliniques universitaires Saint Luc, Université catholique de Louvain, Brussels, Belgium
Ahmad Awada
Head, Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Antoinette J Wozniak
Associate Director of Clinical Research; Director, Lung Cancer Disease Unit; Co-Director, UPMC Lung Cancer Center of Excellence, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
Ulka Vaishampayan
Professor of Internal Medicine, Division of Hematology and Oncology; Director of Phase I Therapeutics, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA
Andrew I Schafer
E. Hugh Luckey Distinguished Professor of Medicine; Director, Richard T. Silver Center for Myeloproliferative Neoplasms, Weill Cornell Medical College, New York, NY, USA
Michael J Morris
Prostate Cancer Section Head, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Charles D Lopez
Associate Professor of Medicine, Hematology and Medical Oncology, Cell and Developmental Biology, Oregon Health & Science University, Portland, OR, USA
Martin J Edelman
Chair; Deputy Cancer Center Director for Clinical Research, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA
Ezra Cohen
Associate Director, Moores Cancer Center, Professor of Medicine, UC San Diego Health, San Diego, CA, US
Tanios Bekaii-Saab
Co-Leader, Gastrointestinal Cancer Program; Senior Associate Consultant, Department of Internal Medicine, Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA
Wadie F Bahou
Chief, Division of Hematology; Professor of Medicine/Haematology, Department of Medicine; Director, Stem Cell Research, Stony Brook University, NY, USA
Robin Foà
Professor of Haematology; Head, Division of Hematology, Sapienza University of Rome, Rome, Italy.
Massimo Dominici
Assistant Professor of Medical Oncology, Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy